|
1
|
Mack TM: Sarcomas and other malignancies
of soft tissue, retroperitoneum, peritoneum, pleura, heart,
mediastinum, and spleen. Cancer. 75 Suppl 1:S211–S244. 1995.
View Article : Google Scholar
|
|
2
|
Nathan H, Raut CP, Thornton K, Herman JM,
Ahuja N, Schulick RD, Choti MA and Pawlik TM: Predictors of
survival after resection of retroperitoneal sarcoma: A
population-based analysis and critical appraisal of the AJCC
staging system. Ann Surg. 250:970–976. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Porter GA, Baxter NN and Pisters PW:
Retroperitoneal sarcoma: A population-based analysis of
epidemiology, surgery, and radiotherapy. Cancer. 106:1610–1616.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dalai KM, Antonescu CR and Singer S:
Diagnosis and management of lipomatous tumors. J Surg Oncol.
97:298–313. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee SY, Goh BK, Teo MC, Chew MH, Chow PK,
Wong WK, Ooi LL and Soo KC: Retroperitoneal liposarcomas: The
experience of a tertiary Asian center. World J Surg Oncol.
9:122011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fuks D, Verhaeghe JL, Marchal F, Guillemin
F, Beckendorf V, Peiffert D, Leroux A, Rios M, Troufléau P and
Marchal C: Surgery and postoperative radiation therapy in primary
retroperitoneal sarcomas: Experience of the cancer centre
Alexis-Vautrin. Cancer Radiother. 16:194–200. 2012.(In French).
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
EI-Bared N, Taussky D, Mehiri S, Patocskai
E, Roberge D and Donath D: Preoperative intensity modulated
radiation therapy for retroperitoneal sarcoma. Technol Cancer Res
Treat. 13:211–216. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Alldinger I, Yang Q, Pilarsky C, Saeger
HD, Knoefel WT and Peiper M: Retroperitoneal soft tissue sarcomas:
Prognosis and treatment of primary and recurrent disease in 117
patients. Anticancer Res. 26:1577–1581. 2006.PubMed/NCBI
|
|
9
|
Rubin BP and Fletcher CD: The
cytologenetics of lipomatous tumours. Histopathology. 30:507–511.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ma YL, Peng JY, Zhang P, Liu WJ, Huang L
and Qin HL: Immunohistochemical analysis revealed CD34 and Ki67
protein expression as significant prognostic factors in coloreetal
cancer. Med Oncol. 27:304–309. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Miettinen M and Lasota J: Gastrointestinal
stromal tumors-definition, clinical, histological,
immunohistochemical, and molecular genetic features and
differential diagnosis. Virchows Arch. 438:1–12. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Czyzewska J, Guzińska-Ustymowicz K, Lebelt
A, Zalewski B and Kemona A: Evaluation of proliferating markers
Ki-67, PCNA in gastric cancers. Rocz Akad Med Bialymst. 49 Suppl
1:S64–S66. 2004.
|
|
13
|
Na JC, Choi KH, Yang SC and Han WK:
Surgical experience with retroperitoneal liposarcoma in a single
korean tertiary medical center. Korean J Urol. 53:310–316. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tseng WW, Madewell JE, Wei W, Somaiah N,
Lazar AJ, Ghadimi MP, Hoffman A, Pisters PW, Lev DC and Pollock RE:
Locoregional disease patterns in well-differentiated and
de-differentiated retroperitoneal liposarcoma: Implications for the
extent of resection? Ann Surg Oncol. 21:2136–2143. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guillou L and Aurias A: Soft tissue
sarcomas with complex genomic profiles. Virchows Arch. 456:201–217.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Stout AP: Liposarcoma-the malignant tumor
of lipoblasts. Ann Surg. 119:86–107. 1944. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Singer S, Antonescu CR, Riedel E and
Brennan MF: Histologic subtype and margin of resection predict
pattern of recurrence and survival for retroperitoneal liposarcoma.
Ann Surg. 238:358–370. 2003.PubMed/NCBI
|
|
18
|
Liu JJ, Liu JY, Chen J, Wu YX, Yan P, Ji
CD, Wang YX, Xiang DF, Zhang X, Zhang P, et al: Scinderin promotes
the invasion and metastasis of gastric cancer cells and predicts
the outcome of patients. Cancer Lett. 376:110–117. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mendenhall WM, Zlotecki RA, Hochwald SN,
Hemming AW, Grobmyer SR and Cance WG: Retroperitoneal soft tissue
sarcoma. Cancer. 104:669–675. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Herrera-Gómez A, Ortega-Gutiérrez C,
Betancourt AM and Luna-Ortiz K: Giant retroperitoneal liposarcoma.
World J Surg Oncol. 6:1152008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yoshida Y, Inoue K, Ohsako T, Nagamoto N,
Tanaka E and Tsuruzoe S: Weekly paclitaxel therapy is curative for
patients with retroperitoneal liposarcoma. Gan to Kagaku Ryoho.
34:465–467. 2007.(In Japanese). PubMed/NCBI
|
|
22
|
Windham TC and Pisters PW: Retroperitoneal
sarcomas. Cancer Control. 12:36–43. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Paryani NN, Zlotecki RA, Swanson EL,
Morris CG, Grobmyer SR, Hochwald SN, Marcus RB Jr and Indelicato
DJ: Multimodality local therapy for retroperitoneal sarcoma. Int J
Radiat Oncol Biol Phys. 82:1128–1134. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tseng WH, Martinez SR, Do L, Tamurian RM,
Borys D and Canter RJ: Lack of survival benefit following adjuvant
radiation in patients with retroperitoneal sarcoma: A SEER
analysis. J Surg Res. 168:e173–e180. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Neuhaus SJ, Barry P, Clark MA, Hayes AJ,
Fisher C and Thomas JM: Surgical management of primary and
recurrent retroperitoneal liposarcoma. Br J Surg. 92:246–252. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dalal KM, Kattan MW, Antonescu CR, Brennan
MF and Singer S: Subtype specific prognostic nomogram for patients
with primary liposarcoma of the retroperitoneum, extremity, or
trunk. Ann Surg. 244:381–391. 2006.PubMed/NCBI
|
|
27
|
Eilber FC, Eilber FR, Eckardt J, Rosen G,
Riedel E, Maki RG, Brennan MF and Singer S: The impact of
chemotherapy on the survival of patients with high-grade primary
extremity liposarcoma. Ann Surg. 240:686–695. 2004.PubMed/NCBI
|
|
28
|
Stilidi IS, Nikulin MP, Nered SN, Davydov
MM, Bolotskiĭ VI and Gubina GI: Combined operations by
retroperitoneal liposarcoma. Khirurgiia (Mosk). 1–25. 2013.
|
|
29
|
Weiss SW, Sobin LH and Enzinger FM:
Histologic typing of soft tissue tumors. World Health Organization
International Histological Classification of Tumours. 2th.
Springer-Verlag; Berlin, Germany: pp. 23–26. 1994
|
|
30
|
Fabre-Guillevin E, Coindre JM, Nde S
Somerhausen, Bonichon F, Stoeckle E and Bui NB: Retroperitoneal
liposarcomas: Follow-up analysis of dedifferentiation after
clinicopathologic reexamination of 86 liposarcomas and malignant
fibrous histiocytomas. Cancer. 106:2725–2733. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang L, Ren W, Zhou X, Sheng W and Wang J:
Pleomorphic liposarcoma: A clinicopathological, immunohistochemical
and molecular cytogenetic study of 32 additional cases. Pathol Int.
63:523–531. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cheng J, Yu H, Wang L, Wang X and Shen G:
Primary oral and maxillofacial liposarcoma: A clinicopathological
and immunohistochemical study of eleven cases. Arch Med Sci.
8:316–323. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dziegiel P, Salwa-Zurawska W, Zurawski J,
Wojnar A and Zabel M: Prognostic significance of augmented
metallothionein (MT) expression correlated with Ki-67 antigen
expression in selected soft tissue sarcomas. Histol Histopathol.
20:83–89. 2005.PubMed/NCBI
|
|
34
|
Wang HJ, Li CY and Wang YK: Diagnostic
implications of Ki-67 expression in adipocytes and lipoblasts: An
immunohistochemical study. Int J Clin Exp Pathol. 7:8899–8904.
2014.PubMed/NCBI
|
|
35
|
Yu JQ, Zhou Q, Zheng YF and Bao Y:
Expression of Vimentin and Ki-67 proteins in cervical squamous cell
carcinoma and their relationships with clinicopathological
features. Asian Pac J Cancer Prev. 16:4271–4275. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wintzer HO, Zipfel I, Schulte-Mönting J,
Hellerich U and von Kleist S: Ki-67 immunostaining in human breast
tumors and its relationship to prognosis. Cancer. 67:421–428. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tseng W, Martinez SR, Tamurian RM, Borys D
and Canter RJ: Histologic type predicts survival in patients with
rrtroperitoneal soft tissue sarcoma. J Surg Res. 172:123–130. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Serio G, Tenehini P, Nifosi F and Iacono
C: Surgical strategy in primary retroperitoneal tumours. Br J Surg.
76:385–389. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Singer S, Corson JM, Demetri GD, Healey
EA, Marcus K and Eberlein TJ: Prognostic factors predictive of
survival for truncal and retroperitoneal soft-tissue sarcoma. Ann
Surg. 221:185–195. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Vijay A and Ram L: Retroperitoneal
liposarcoma: A comprehensive review. Am J Clin Oncol. 38:213–219.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lewis JJ, Leung D, Woodruff JM and Brennan
MF: Retroperitoneal soft-tissue sarcoma: Analysis of 500 patients
treated and followed at a single institution. Ann Surg.
228:355–365. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Milone M, Pezzullo LS, Salvatore G,
Pezzullo MG, Leongito M, Esposito I and Milone F: Management of
high-grade retroperitoneal liposarcomas: Personal experience.
Updates Surg. 63:119–124. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bonvalot S, Miceli R, Berselli M, Causeret
S, Colombo C, Mariani L, Bouzaiene H, Le Péchoux C, Casali PG, Le
Cesne A, et al: Aggressive surgery in retroperitoneal soft tissue
sarcoma carried out at high-volume centers is safe and is
associated with improved local control. Ann Surg Oncol.
17:1507–1514. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Clark MA and Thomas JM: Portsite
recurrence after laparoscopy for staging of retroperitoneal
sarcoma. Surg Laparosc Endosc Percutan Tech. 13:290–291. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Shibata D, Lewis JJ, Leung DH and Brennan
MF: Is there a role for incomplete resection in the management of
retroperitoneal liposarcomas? J Am Coll Surg. 193:373–379. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sato T, Yamaguchi T, Azekura K, Ueno M,
Ohyama S, Ohya M, Yamamoto J, Muto T, Ishikawa Y and Kanda H:
Repeated resection for intra-abdominal and retroperitoneal
liposarcoma: Long-term experience in a single cancer in Japan. Int
Surg. 91:267–271. 2006.PubMed/NCBI
|
|
47
|
Chikatani K, Baba H, Sobajima J, Ishiguro
T, Kumamoto K, Kumagai Y, Ishibashi K, Haga N, Tsuji Y, Iwama T and
Ishida H: Clinicopathological characteristics and treatment outcome
of retroperitoneal liposarcoma. Gan To Kagaku Ryoho. 39:2426–2428.
2012.(In Japanese). PubMed/NCBI
|
|
48
|
Huang XH, Li PY, Zhao XD and Liu N: The
therapeutic strategy of primary retroperitoneal liposarcoma. Chin J
Pract Surg. 2:156–158. 2013.(In Chinese).
|
|
49
|
Theodosopoulos T, Psychogiou V, Yiallourou
AI, Polymeneas G, Kondi-Pafiti A, Papaconstantinou I and Voros D:
Management of retroperitoneal sarcomas: Main prognostic factors for
local recurrence and survival. J BUON. 17:138–142. 2012.PubMed/NCBI
|
|
50
|
Park JO, Qin LX, Prete FP, Antonescu C,
Brennan MF and Singer S: Predicting outcome by growth rate of
locally recurrent retroperitoneal liposarcoma: The one centimeter
per month rule. Ann Surg. 250:977–982. 2009. View Article : Google Scholar : PubMed/NCBI
|
